Quick Answer
Evening Primrose Skin Randomized Trial has evidence relevant to safety, limits, and clinician-discussion contexts, but conclusions should stay close to the cited sources. One representative finding is: Napheys in 1981 described it as an “unpleasant train of symptoms that can be alarming, painful, and often entailing sad consequences, though rarely fatal.” He found that physicians tended to ridicule these complaints [].
Key Takeaways
- 01Napheys in 1981 described it as an “unpleasant train of symptoms that can be alarming, painful, and often entailing sad consequences, though rarely fatal.” He found that physicians tended to ridicule these complaints []. [Thevi Thanigasalam (2024)]
- 02Randomized trials have not only shown no benefit in HRT for menopause but also shown that there is an increased risk of coronary heart disease (CHD) and breast cancer []. [Thevi Thanigasalam (2024)]
- 03There are controversies about the risk of HRT and ovarian cancer about whether the risk is small [] or not significant []. [Thevi Thanigasalam (2024)]
- 04Menopause, which is cessation of menstruation is a physiological process of the female reproductive system. [Thevi Thanigasalam (2024)]
The current Migaku evidence database contains 2 reusable source documents for Evening Primrose Skin Randomized Trial. This answer focuses on safety, limits, and clinician-discussion contexts.
- Napheys in 1981 described it as an “unpleasant train of symptoms that can be alarming, painful, and often entailing sad consequences, though rarely fatal.” He found that physicians tended to ridicule these complaints []. [Thevi Thanigasalam (2024); evidence level 1]
- Randomized trials have not only shown no benefit in HRT for menopause but also shown that there is an increased risk of coronary heart disease (CHD) and breast cancer []. [Thevi Thanigasalam (2024); evidence level 1]
- There are controversies about the risk of HRT and ovarian cancer about whether the risk is small [] or not significant []. [Thevi Thanigasalam (2024); evidence level 1]
- Menopause, which is cessation of menstruation is a physiological process of the female reproductive system. [Thevi Thanigasalam (2024); evidence level 1]
- Mastalgia is a common breast complaint in women, particularly those of reproductive age, often leading to significant physical and psychological distress. [Arya A (2025); evidence level 4]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources